nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS3—Doxorubicin—uterine cancer	0.29	0.413	CbGbCtD
L-Arginine—NOS2—Doxorubicin—uterine cancer	0.29	0.413	CbGbCtD
L-Arginine—SLC22A5—Dactinomycin—uterine cancer	0.121	0.173	CbGbCtD
L-Arginine—Choking—Progesterone—uterine cancer	0.0129	0.155	CcSEcCtD
L-Arginine—ASS1—oviduct—uterine cancer	0.00805	0.0517	CbGeAlD
L-Arginine—AZIN2—myometrium—uterine cancer	0.00705	0.0453	CbGeAlD
L-Arginine—SLC7A3—decidua—uterine cancer	0.00586	0.0377	CbGeAlD
L-Arginine—AZIN2—uterine cervix—uterine cancer	0.00549	0.0352	CbGeAlD
L-Arginine—NOS3—artery—uterine cancer	0.00531	0.0341	CbGeAlD
L-Arginine—Extravasation—Carboplatin—uterine cancer	0.00516	0.0616	CcSEcCtD
L-Arginine—ASL—uterine cervix—uterine cancer	0.0051	0.0327	CbGeAlD
L-Arginine—ASL—renal system—uterine cancer	0.00477	0.0306	CbGeAlD
L-Arginine—SLC7A4—female reproductive system—uterine cancer	0.00429	0.0275	CbGeAlD
L-Arginine—ASL—uterus—uterine cancer	0.00425	0.0273	CbGeAlD
L-Arginine—ASL—female reproductive system—uterine cancer	0.00382	0.0245	CbGeAlD
L-Arginine—AZIN2—female gonad—uterine cancer	0.00374	0.024	CbGeAlD
L-Arginine—AZIN2—vagina—uterine cancer	0.00372	0.0239	CbGeAlD
L-Arginine—ASS1—Norethindrone—Progesterone—uterine cancer	0.00353	1	CbGdCrCtD
L-Arginine—ASL—female gonad—uterine cancer	0.00348	0.0223	CbGeAlD
L-Arginine—Skin necrosis—Etoposide—uterine cancer	0.00346	0.0413	CcSEcCtD
L-Arginine—SLC7A1—renal system—uterine cancer	0.00313	0.0201	CbGeAlD
L-Arginine—ARG2—epithelium—uterine cancer	0.00288	0.0185	CbGeAlD
L-Arginine—ARG2—uterine cervix—uterine cancer	0.00286	0.0184	CbGeAlD
L-Arginine—SLC7A1—uterus—uterine cancer	0.00279	0.0179	CbGeAlD
L-Arginine—Necrosis—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.0326	CcSEcCtD
L-Arginine—ARG2—renal system—uterine cancer	0.00267	0.0172	CbGeAlD
L-Arginine—ARG2—endometrium—uterine cancer	0.00259	0.0166	CbGeAlD
L-Arginine—ASS1—myometrium—uterine cancer	0.00257	0.0165	CbGeAlD
L-Arginine—SLC7A1—female reproductive system—uterine cancer	0.0025	0.0161	CbGeAlD
L-Arginine—ARG2—mammalian vulva—uterine cancer	0.0025	0.0161	CbGeAlD
L-Arginine—AZIN2—lymph node—uterine cancer	0.0024	0.0154	CbGeAlD
L-Arginine—ARG2—uterus—uterine cancer	0.00238	0.0153	CbGeAlD
L-Arginine—SLC7A1—female gonad—uterine cancer	0.00228	0.0146	CbGeAlD
L-Arginine—ASL—lymph node—uterine cancer	0.00224	0.0144	CbGeAlD
L-Arginine—ARG2—female reproductive system—uterine cancer	0.00214	0.0138	CbGeAlD
L-Arginine—Injection site reaction—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.0254	CcSEcCtD
L-Arginine—Necrosis—Dactinomycin—uterine cancer	0.00213	0.0254	CcSEcCtD
L-Arginine—ASS1—epithelium—uterine cancer	0.00202	0.013	CbGeAlD
L-Arginine—NOS3—epithelium—uterine cancer	0.00201	0.0129	CbGeAlD
L-Arginine—ASS1—uterine cervix—uterine cancer	0.002	0.0129	CbGeAlD
L-Arginine—ARG2—female gonad—uterine cancer	0.00195	0.0125	CbGeAlD
L-Arginine—ASS1—smooth muscle tissue—uterine cancer	0.00195	0.0125	CbGeAlD
L-Arginine—Swelling—Progesterone—uterine cancer	0.00194	0.0232	CcSEcCtD
L-Arginine—NOS3—smooth muscle tissue—uterine cancer	0.00194	0.0125	CbGeAlD
L-Arginine—Skin necrosis—Epirubicin—uterine cancer	0.00194	0.0232	CcSEcCtD
L-Arginine—ARG2—vagina—uterine cancer	0.00194	0.0124	CbGeAlD
L-Arginine—Extravasation—Dactinomycin—uterine cancer	0.00191	0.0229	CcSEcCtD
L-Arginine—ASS1—decidua—uterine cancer	0.00191	0.0123	CbGeAlD
L-Arginine—ASS1—renal system—uterine cancer	0.00187	0.012	CbGeAlD
L-Arginine—NOS3—renal system—uterine cancer	0.00187	0.012	CbGeAlD
L-Arginine—ASS1—endometrium—uterine cancer	0.00181	0.0116	CbGeAlD
L-Arginine—Skin necrosis—Doxorubicin—uterine cancer	0.00179	0.0214	CcSEcCtD
L-Arginine—Swelling—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.0211	CcSEcCtD
L-Arginine—ASS1—mammalian vulva—uterine cancer	0.00175	0.0113	CbGeAlD
L-Arginine—ASS1—uterus—uterine cancer	0.00167	0.0107	CbGeAlD
L-Arginine—SLC22A4—myometrium—uterine cancer	0.00164	0.0105	CbGeAlD
L-Arginine—Necrosis—Etoposide—uterine cancer	0.00154	0.0184	CcSEcCtD
L-Arginine—ASS1—female reproductive system—uterine cancer	0.0015	0.00964	CbGeAlD
L-Arginine—NOS3—female reproductive system—uterine cancer	0.0015	0.00961	CbGeAlD
L-Arginine—SLC7A1—lymph node—uterine cancer	0.00147	0.00941	CbGeAlD
L-Arginine—Numbness—Etoposide—uterine cancer	0.00146	0.0174	CcSEcCtD
L-Arginine—SLC16A10—epithelium—uterine cancer	0.00144	0.00927	CbGeAlD
L-Arginine—Sensory loss—Etoposide—uterine cancer	0.0014	0.0167	CcSEcCtD
L-Arginine—Extravasation—Etoposide—uterine cancer	0.00139	0.0166	CcSEcCtD
L-Arginine—ASS1—female gonad—uterine cancer	0.00137	0.00877	CbGeAlD
L-Arginine—ASS1—vagina—uterine cancer	0.00136	0.00872	CbGeAlD
L-Arginine—NOS3—vagina—uterine cancer	0.00135	0.00869	CbGeAlD
L-Arginine—ARG2—lymph node—uterine cancer	0.00125	0.00805	CbGeAlD
L-Arginine—SLC16A10—mammalian vulva—uterine cancer	0.00125	0.00804	CbGeAlD
L-Arginine—Lethargy—Dactinomycin—uterine cancer	0.00124	0.0148	CcSEcCtD
L-Arginine—SLC22A4—decidua—uterine cancer	0.00121	0.0078	CbGeAlD
L-Arginine—SLC22A4—renal system—uterine cancer	0.00119	0.00766	CbGeAlD
L-Arginine—Skin exfoliation—Etoposide—uterine cancer	0.00115	0.0138	CcSEcCtD
L-Arginine—SLC22A4—endometrium—uterine cancer	0.00115	0.0074	CbGeAlD
L-Arginine—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.0137	CcSEcCtD
L-Arginine—SLC22A5—myometrium—uterine cancer	0.00108	0.00696	CbGeAlD
L-Arginine—SLC16A10—female reproductive system—uterine cancer	0.00107	0.00689	CbGeAlD
L-Arginine—Swelling—Etoposide—uterine cancer	0.000995	0.0119	CcSEcCtD
L-Arginine—SLC16A10—vagina—uterine cancer	0.00097	0.00623	CbGeAlD
L-Arginine—SLC22A4—female reproductive system—uterine cancer	0.000955	0.00613	CbGeAlD
L-Arginine—ASS1—lymph node—uterine cancer	0.000878	0.00564	CbGeAlD
L-Arginine—NOS3—lymph node—uterine cancer	0.000875	0.00562	CbGeAlD
L-Arginine—SLC22A4—vagina—uterine cancer	0.000864	0.00555	CbGeAlD
L-Arginine—Necrosis—Epirubicin—uterine cancer	0.000863	0.0103	CcSEcCtD
L-Arginine—SLC22A5—uterine cervix—uterine cancer	0.000844	0.00542	CbGeAlD
L-Arginine—Anaphylactic shock—Progesterone—uterine cancer	0.000843	0.0101	CcSEcCtD
L-Arginine—Tachycardia—Progesterone—uterine cancer	0.000823	0.00983	CcSEcCtD
L-Arginine—Hyperhidrosis—Progesterone—uterine cancer	0.000815	0.00974	CcSEcCtD
L-Arginine—Anorexia—Progesterone—uterine cancer	0.000804	0.0096	CcSEcCtD
L-Arginine—Necrosis—Doxorubicin—uterine cancer	0.000799	0.00954	CcSEcCtD
L-Arginine—SLC22A5—renal system—uterine cancer	0.000789	0.00507	CbGeAlD
L-Arginine—Flushing—Dactinomycin—uterine cancer	0.000778	0.0093	CcSEcCtD
L-Arginine—Extravasation—Epirubicin—uterine cancer	0.000777	0.00928	CcSEcCtD
L-Arginine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000764	0.00913	CcSEcCtD
L-Arginine—SLC22A5—endometrium—uterine cancer	0.000763	0.0049	CbGeAlD
L-Arginine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000746	0.00891	CcSEcCtD
L-Arginine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000739	0.00882	CcSEcCtD
L-Arginine—Decreased appetite—Progesterone—uterine cancer	0.000733	0.00876	CcSEcCtD
L-Arginine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000728	0.0087	CcSEcCtD
L-Arginine—Extravasation—Doxorubicin—uterine cancer	0.000719	0.00859	CcSEcCtD
L-Arginine—Injection site reaction—Epirubicin—uterine cancer	0.000674	0.00805	CcSEcCtD
L-Arginine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000664	0.00794	CcSEcCtD
L-Arginine—Skin exfoliation—Epirubicin—uterine cancer	0.000647	0.00773	CcSEcCtD
L-Arginine—SLC22A5—female reproductive system—uterine cancer	0.000632	0.00406	CbGeAlD
L-Arginine—SLC16A10—lymph node—uterine cancer	0.000627	0.00403	CbGeAlD
L-Arginine—Injection site reaction—Doxorubicin—uterine cancer	0.000623	0.00745	CcSEcCtD
L-Arginine—Hypersensitivity—Progesterone—uterine cancer	0.000621	0.00742	CcSEcCtD
L-Arginine—Hypoaesthesia—Etoposide—uterine cancer	0.000604	0.00722	CcSEcCtD
L-Arginine—Skin exfoliation—Doxorubicin—uterine cancer	0.000599	0.00715	CcSEcCtD
L-Arginine—SLC22A5—female gonad—uterine cancer	0.000575	0.00369	CbGeAlD
L-Arginine—SLC22A5—vagina—uterine cancer	0.000572	0.00367	CbGeAlD
L-Arginine—Anorexia—Dactinomycin—uterine cancer	0.000568	0.00679	CcSEcCtD
L-Arginine—Flushing—Etoposide—uterine cancer	0.000563	0.00673	CcSEcCtD
L-Arginine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000563	0.00673	CcSEcCtD
L-Arginine—SLC22A4—lymph node—uterine cancer	0.000559	0.00359	CbGeAlD
L-Arginine—Vomiting—Progesterone—uterine cancer	0.000536	0.00641	CcSEcCtD
L-Arginine—Rash—Progesterone—uterine cancer	0.000532	0.00635	CcSEcCtD
L-Arginine—Dermatitis—Progesterone—uterine cancer	0.000531	0.00635	CcSEcCtD
L-Arginine—Headache—Progesterone—uterine cancer	0.000528	0.00631	CcSEcCtD
L-Arginine—Decreased appetite—Dactinomycin—uterine cancer	0.000518	0.00619	CcSEcCtD
L-Arginine—L-Methionine—MTHFR—uterine cancer	0.000512	1	CrCbGaD
L-Arginine—Lethargy—Epirubicin—uterine cancer	0.000502	0.006	CcSEcCtD
L-Arginine—Nausea—Progesterone—uterine cancer	0.000501	0.00598	CcSEcCtD
L-Arginine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000486	0.0058	CcSEcCtD
L-Arginine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000482	0.00576	CcSEcCtD
L-Arginine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000481	0.00575	CcSEcCtD
L-Arginine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000479	0.00572	CcSEcCtD
L-Arginine—Lethargy—Doxorubicin—uterine cancer	0.000464	0.00555	CcSEcCtD
L-Arginine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000454	0.00542	CcSEcCtD
L-Arginine—Hypersensitivity—Dactinomycin—uterine cancer	0.000439	0.00525	CcSEcCtD
L-Arginine—Anaphylactic shock—Etoposide—uterine cancer	0.000431	0.00515	CcSEcCtD
L-Arginine—Tachycardia—Etoposide—uterine cancer	0.000421	0.00503	CcSEcCtD
L-Arginine—Hyperhidrosis—Etoposide—uterine cancer	0.000417	0.00498	CcSEcCtD
L-Arginine—Anorexia—Etoposide—uterine cancer	0.000411	0.00491	CcSEcCtD
L-Arginine—AZIN2—Metabolism—STAR—uterine cancer	0.000394	0.00699	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKR1B1—uterine cancer	0.000394	0.00699	CbGpPWpGaD
L-Arginine—Vomiting—Dactinomycin—uterine cancer	0.000379	0.00453	CcSEcCtD
L-Arginine—Rash—Dactinomycin—uterine cancer	0.000376	0.00449	CcSEcCtD
L-Arginine—Decreased appetite—Etoposide—uterine cancer	0.000375	0.00448	CcSEcCtD
L-Arginine—SLC22A5—lymph node—uterine cancer	0.00037	0.00237	CbGeAlD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—uterine cancer	0.000368	0.00654	CbGpPWpGaD
L-Arginine—NOS3—VEGFR1 specific signals—VEGFA—uterine cancer	0.000363	0.00645	CbGpPWpGaD
L-Arginine—Sweating—Epirubicin—uterine cancer	0.000363	0.00434	CcSEcCtD
L-Arginine—Haematuria—Epirubicin—uterine cancer	0.000361	0.00432	CcSEcCtD
L-Arginine—ASL—Metabolism—STAR—uterine cancer	0.00036	0.00639	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKR1B1—uterine cancer	0.00036	0.00639	CbGpPWpGaD
L-Arginine—Nausea—Dactinomycin—uterine cancer	0.000354	0.00423	CcSEcCtD
L-Arginine—Hypoaesthesia—Epirubicin—uterine cancer	0.000339	0.00405	CcSEcCtD
L-Arginine—Sweating—Doxorubicin—uterine cancer	0.000336	0.00402	CcSEcCtD
L-Arginine—Haematuria—Doxorubicin—uterine cancer	0.000334	0.004	CcSEcCtD
L-Arginine—NOS3—Angiogenesis—PIK3CA—uterine cancer	0.00033	0.00587	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—CXCL8—uterine cancer	0.000327	0.0058	CbGpPWpGaD
L-Arginine—NOS3—Metabolism of nitric oxide—AKT1—uterine cancer	0.000325	0.00578	CbGpPWpGaD
L-Arginine—Hypersensitivity—Etoposide—uterine cancer	0.000318	0.0038	CcSEcCtD
L-Arginine—Flushing—Epirubicin—uterine cancer	0.000316	0.00377	CcSEcCtD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—uterine cancer	0.000316	0.00561	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000313	0.00374	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—EZH2—uterine cancer	0.000313	0.00556	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—uterine cancer	0.000311	0.00552	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—POLD1—uterine cancer	0.000309	0.00549	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	0.000304	0.0054	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—PIK3CA—uterine cancer	0.000301	0.00534	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—ESR1—uterine cancer	0.000301	0.00534	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—YWHAE—uterine cancer	0.0003	0.00534	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKR1B1—uterine cancer	0.000298	0.0053	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—STAR—uterine cancer	0.000298	0.0053	CbGpPWpGaD
L-Arginine—Flushing—Doxorubicin—uterine cancer	0.000292	0.00349	CcSEcCtD
L-Arginine—AZIN2—Metabolism—AKR1C1—uterine cancer	0.000289	0.00513	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—SRD5A2—uterine cancer	0.000286	0.00508	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NDUFB11—uterine cancer	0.000286	0.00508	CbGpPWpGaD
L-Arginine—NOS3—VEGFR1 specific signals—PIK3CA—uterine cancer	0.000284	0.00504	CbGpPWpGaD
L-Arginine—ASL—Metabolism—POLD1—uterine cancer	0.000283	0.00502	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—EP300—uterine cancer	0.00028	0.00497	CbGpPWpGaD
L-Arginine—Vomiting—Etoposide—uterine cancer	0.000274	0.00328	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	0.000272	0.00483	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—uterine cancer	0.000272	0.00483	CbGpPWpGaD
L-Arginine—Rash—Etoposide—uterine cancer	0.000272	0.00325	CcSEcCtD
L-Arginine—Dermatitis—Etoposide—uterine cancer	0.000272	0.00325	CcSEcCtD
L-Arginine—Headache—Etoposide—uterine cancer	0.00027	0.00323	CcSEcCtD
L-Arginine—NOS3—Angiogenesis—AKT1—uterine cancer	0.00027	0.00479	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKR1C1—uterine cancer	0.000264	0.00469	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—RRM2—uterine cancer	0.000258	0.00457	CbGpPWpGaD
L-Arginine—Nausea—Etoposide—uterine cancer	0.000256	0.00306	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—EP300—uterine cancer	0.000256	0.00455	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—DCN—uterine cancer	0.00025	0.00444	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	0.000242	0.00431	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Epirubicin—uterine cancer	0.000242	0.00289	CcSEcCtD
L-Arginine—NOS3—VEGFR2 mediated vascular permeability—AKT1—uterine cancer	0.000239	0.00424	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CCL2—uterine cancer	0.000237	0.00421	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—uterine cancer	0.000237	0.0042	CbGpPWpGaD
L-Arginine—Tachycardia—Epirubicin—uterine cancer	0.000236	0.00282	CcSEcCtD
L-Arginine—ASL—Metabolism—RRM2—uterine cancer	0.000236	0.00418	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CYP11A1—uterine cancer	0.000236	0.00418	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	0.000234	0.00416	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—POLD1—uterine cancer	0.000234	0.00416	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Epirubicin—uterine cancer	0.000234	0.00279	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—AKT1—uterine cancer	0.000232	0.00412	CbGpPWpGaD
L-Arginine—Anorexia—Epirubicin—uterine cancer	0.00023	0.00275	CcSEcCtD
L-Arginine—ASL—Metabolism—DCN—uterine cancer	0.000229	0.00406	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000224	0.00267	CcSEcCtD
L-Arginine—AZIN2—Metabolism—AKR1C3—uterine cancer	0.000222	0.00395	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—ERBB2—uterine cancer	0.000221	0.00392	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKR1C1—uterine cancer	0.000219	0.00389	CbGpPWpGaD
L-Arginine—Tachycardia—Doxorubicin—uterine cancer	0.000218	0.00261	CcSEcCtD
L-Arginine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000216	0.00258	CcSEcCtD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000216	0.00383	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CYP11A1—uterine cancer	0.000215	0.00383	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	0.000215	0.00382	CbGpPWpGaD
L-Arginine—Anorexia—Doxorubicin—uterine cancer	0.000213	0.00255	CcSEcCtD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000212	0.00377	CbGpPWpGaD
L-Arginine—Decreased appetite—Epirubicin—uterine cancer	0.00021	0.00251	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—uterine cancer	0.000209	0.00371	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—VEGFA—uterine cancer	0.000209	0.00371	CbGpPWpGaD
L-Arginine—NOS3—PAR1-mediated thrombin signaling events—PIK3CA—uterine cancer	0.000207	0.00368	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—STAR—uterine cancer	0.000207	0.00367	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKR1B1—uterine cancer	0.000207	0.00367	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—NRAS—uterine cancer	0.000206	0.00366	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—uterine cancer	0.000204	0.00362	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKR1C3—uterine cancer	0.000203	0.00361	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	0.000199	0.00354	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—RRM2—uterine cancer	0.000195	0.00347	CbGpPWpGaD
L-Arginine—Decreased appetite—Doxorubicin—uterine cancer	0.000194	0.00232	CcSEcCtD
L-Arginine—ARG2—Metabolism—DCN—uterine cancer	0.000189	0.00336	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CXCL8—uterine cancer	0.000188	0.00333	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—PIK3CA—uterine cancer	0.000187	0.00332	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—uterine cancer	0.000184	0.00326	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—uterine cancer	0.000184	0.00326	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CDKN1B—uterine cancer	0.000183	0.00325	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—uterine cancer	0.000181	0.00321	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CYP11A1—uterine cancer	0.000179	0.00317	CbGpPWpGaD
L-Arginine—Hypersensitivity—Epirubicin—uterine cancer	0.000178	0.00213	CcSEcCtD
L-Arginine—NOS3—Corticotropin-releasing hormone—CXCL8—uterine cancer	0.000178	0.00316	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—KRAS—uterine cancer	0.000177	0.00315	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	0.000176	0.00312	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CYP19A1—uterine cancer	0.000173	0.00308	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—STK11—uterine cancer	0.000173	0.00308	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—uterine cancer	0.000173	0.00307	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKR1C3—uterine cancer	0.000169	0.00299	CbGpPWpGaD
L-Arginine—Hypersensitivity—Doxorubicin—uterine cancer	0.000165	0.00197	CcSEcCtD
L-Arginine—NOS3—Corticotropin-releasing hormone—CTNNB1—uterine cancer	0.000164	0.00291	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—PIK3CA—uterine cancer	0.000163	0.0029	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—POLD1—uterine cancer	0.000162	0.00288	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000162	0.00288	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IRF1—uterine cancer	0.000161	0.00285	CbGpPWpGaD
L-Arginine—ASL—Metabolism—STK11—uterine cancer	0.000158	0.00281	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CYP19A1—uterine cancer	0.000158	0.00281	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—AKT1—uterine cancer	0.000155	0.00275	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	0.000155	0.00275	CbGpPWpGaD
L-Arginine—Vomiting—Epirubicin—uterine cancer	0.000154	0.00184	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—AKT1—uterine cancer	0.000153	0.00271	CbGpPWpGaD
L-Arginine—Rash—Epirubicin—uterine cancer	0.000152	0.00182	CcSEcCtD
L-Arginine—Dermatitis—Epirubicin—uterine cancer	0.000152	0.00182	CcSEcCtD
L-Arginine—ASS1—Metabolism—AKR1C1—uterine cancer	0.000152	0.0027	CbGpPWpGaD
L-Arginine—Headache—Epirubicin—uterine cancer	0.000151	0.00181	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—HRAS—uterine cancer	0.000151	0.00268	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—AKT1—uterine cancer	0.00015	0.00266	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKR1B10—uterine cancer	0.000149	0.00264	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—CTNNB1—uterine cancer	0.000145	0.00258	CbGpPWpGaD
L-Arginine—Nausea—Epirubicin—uterine cancer	0.000144	0.00172	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—PIK3CA—uterine cancer	0.000144	0.00255	CbGpPWpGaD
L-Arginine—Vomiting—Doxorubicin—uterine cancer	0.000142	0.0017	CcSEcCtD
L-Arginine—Rash—Doxorubicin—uterine cancer	0.000141	0.00169	CcSEcCtD
L-Arginine—Dermatitis—Doxorubicin—uterine cancer	0.000141	0.00168	CcSEcCtD
L-Arginine—Headache—Doxorubicin—uterine cancer	0.00014	0.00167	CcSEcCtD
L-Arginine—NOS3—Signaling by VEGF—CTNNB1—uterine cancer	0.000137	0.00244	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—AKT1—uterine cancer	0.000137	0.00243	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—RRM2—uterine cancer	0.000135	0.0024	CbGpPWpGaD
L-Arginine—Nausea—Doxorubicin—uterine cancer	0.000133	0.00159	CcSEcCtD
L-Arginine—ARG2—Metabolism—STK11—uterine cancer	0.000131	0.00233	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CYP19A1—uterine cancer	0.000131	0.00233	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—DCN—uterine cancer	0.000131	0.00233	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—MTHFR—uterine cancer	0.00013	0.00231	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—uterine cancer	0.000128	0.00227	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—NRAS—uterine cancer	0.000126	0.00224	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IRF1—uterine cancer	0.000125	0.00222	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NDUFB11—uterine cancer	0.000125	0.00221	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SRD5A2—uterine cancer	0.000125	0.00221	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CYP11A1—uterine cancer	0.000124	0.0022	CbGpPWpGaD
L-Arginine—NOS2—Disease—RNF43—uterine cancer	0.000123	0.00219	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—HRAS—uterine cancer	0.000123	0.00218	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—VEGFA—uterine cancer	0.000121	0.00214	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—AKT1—uterine cancer	0.00012	0.00213	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—NRAS—uterine cancer	0.000119	0.00212	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—ERBB2—uterine cancer	0.000119	0.00212	CbGpPWpGaD
L-Arginine—ASL—Metabolism—MTHFR—uterine cancer	0.000119	0.00212	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—uterine cancer	0.000117	0.00208	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKR1C3—uterine cancer	0.000117	0.00208	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKR1B10—uterine cancer	0.000116	0.00205	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—uterine cancer	0.000115	0.00204	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—PTEN—uterine cancer	0.00011	0.00196	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—KRAS—uterine cancer	0.000109	0.00193	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—AKT1—uterine cancer	0.000108	0.00193	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—EP300—uterine cancer	0.000105	0.00187	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—KRAS—uterine cancer	0.000103	0.00182	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—PTEN—uterine cancer	0.000102	0.0018	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKR1C1—uterine cancer	0.000102	0.0018	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—PIK3CA—uterine cancer	9.99e-05	0.00177	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—MTHFR—uterine cancer	9.87e-05	0.00175	CbGpPWpGaD
L-Arginine—NOS3—Disease—RNF43—uterine cancer	9.58e-05	0.0017	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—PIK3CA—uterine cancer	9.43e-05	0.00167	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—uterine cancer	9.24e-05	0.00164	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—AKT1—uterine cancer	9.21e-05	0.00164	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CYP19A1—uterine cancer	9.1e-05	0.00162	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—STK11—uterine cancer	9.1e-05	0.00162	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—STAR—uterine cancer	9e-05	0.0016	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKR1B1—uterine cancer	9e-05	0.0016	CbGpPWpGaD
L-Arginine—NOS2—Disease—DCN—uterine cancer	8.79e-05	0.00156	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—HRAS—uterine cancer	8.72e-05	0.00155	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—AKT1—uterine cancer	8.16e-05	0.00145	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKR1B10—uterine cancer	8.1e-05	0.00144	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKR1C1—uterine cancer	7.89e-05	0.0014	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKR1C3—uterine cancer	7.82e-05	0.00139	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—KRAS—uterine cancer	7.8e-05	0.00139	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—AKT1—uterine cancer	7.7e-05	0.00137	CbGpPWpGaD
L-Arginine—NOS2—Disease—HMGA1—uterine cancer	7.62e-05	0.00135	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—uterine cancer	7.52e-05	0.00133	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTEN—uterine cancer	7.24e-05	0.00129	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—POLD1—uterine cancer	7.06e-05	0.00125	CbGpPWpGaD
L-Arginine—NOS2—Disease—FBXW7—uterine cancer	6.97e-05	0.00124	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—EP300—uterine cancer	6.91e-05	0.00123	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—MTHFR—uterine cancer	6.84e-05	0.00121	CbGpPWpGaD
L-Arginine—NOS3—Disease—DCN—uterine cancer	6.83e-05	0.00121	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RNF43—uterine cancer	6.71e-05	0.00119	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—uterine cancer	6.63e-05	0.00118	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTEN—uterine cancer	6.63e-05	0.00118	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKR1C1—uterine cancer	6.61e-05	0.00117	CbGpPWpGaD
L-Arginine—ASL—Metabolism—EP300—uterine cancer	6.32e-05	0.00112	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—INHBA—uterine cancer	6.14e-05	0.00109	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKR1C3—uterine cancer	6.07e-05	0.00108	CbGpPWpGaD
L-Arginine—NOS3—Disease—HMGA1—uterine cancer	5.92e-05	0.00105	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—RRM2—uterine cancer	5.89e-05	0.00105	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AKT1—uterine cancer	5.86e-05	0.00104	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—DCN—uterine cancer	5.72e-05	0.00102	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKR1C1—uterine cancer	5.52e-05	0.000981	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTEN—uterine cancer	5.49e-05	0.000975	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN2B—uterine cancer	5.46e-05	0.00097	CbGpPWpGaD
L-Arginine—NOS3—Disease—FBXW7—uterine cancer	5.41e-05	0.000961	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP11A1—uterine cancer	5.39e-05	0.000956	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—EP300—uterine cancer	5.24e-05	0.00093	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CA—uterine cancer	5.11e-05	0.000908	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKR1C3—uterine cancer	5.09e-05	0.000903	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—EP300—uterine cancer	5.02e-05	0.000891	CbGpPWpGaD
L-Arginine—NOS2—Disease—SMAD3—uterine cancer	4.99e-05	0.000886	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGFR2—uterine cancer	4.76e-05	0.000845	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—uterine cancer	4.75e-05	0.000844	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NRAS—uterine cancer	4.69e-05	0.000834	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CA—uterine cancer	4.67e-05	0.00083	CbGpPWpGaD
L-Arginine—NOS2—Disease—MTHFR—uterine cancer	4.58e-05	0.000813	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKR1C3—uterine cancer	4.25e-05	0.000755	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN2B—uterine cancer	4.24e-05	0.000753	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—uterine cancer	4.18e-05	0.000741	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PGR—uterine cancer	4.14e-05	0.000736	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—uterine cancer	4.04e-05	0.000718	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—STK11—uterine cancer	3.96e-05	0.000704	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP19A1—uterine cancer	3.96e-05	0.000704	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—YWHAE—uterine cancer	3.95e-05	0.000702	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—EP300—uterine cancer	3.9e-05	0.000692	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CA—uterine cancer	3.87e-05	0.000688	CbGpPWpGaD
L-Arginine—NOS3—Disease—SMAD3—uterine cancer	3.87e-05	0.000688	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—uterine cancer	3.82e-05	0.000678	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTEN—uterine cancer	3.81e-05	0.000676	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FBXW7—uterine cancer	3.79e-05	0.000673	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CA—uterine cancer	3.71e-05	0.000659	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGFR2—uterine cancer	3.69e-05	0.000656	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—uterine cancer	3.69e-05	0.000655	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NRAS—uterine cancer	3.65e-05	0.000647	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—EP300—uterine cancer	3.63e-05	0.000645	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—uterine cancer	3.59e-05	0.000638	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTHFR—uterine cancer	3.56e-05	0.000631	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—uterine cancer	3.43e-05	0.00061	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STK11—uterine cancer	3.31e-05	0.000588	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—uterine cancer	3.16e-05	0.000562	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—uterine cancer	3.14e-05	0.000557	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SOCS3—uterine cancer	3.1e-05	0.000551	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—uterine cancer	3.03e-05	0.000539	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB2—uterine cancer	2.99e-05	0.00053	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—MTHFR—uterine cancer	2.98e-05	0.000529	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN2B—uterine cancer	2.97e-05	0.000527	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1R—uterine cancer	2.88e-05	0.000512	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CA—uterine cancer	2.88e-05	0.000512	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—uterine cancer	2.79e-05	0.000495	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1B—uterine cancer	2.77e-05	0.000491	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SMAD3—uterine cancer	2.71e-05	0.000482	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CA—uterine cancer	2.68e-05	0.000477	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—uterine cancer	2.67e-05	0.000474	CbGpPWpGaD
L-Arginine—NOS2—Disease—CTNNB1—uterine cancer	2.61e-05	0.000464	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGFR2—uterine cancer	2.59e-05	0.000459	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTEN—uterine cancer	2.55e-05	0.000452	CbGpPWpGaD
L-Arginine—NOS2—Disease—EP300—uterine cancer	2.43e-05	0.000431	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—uterine cancer	2.35e-05	0.000418	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB2—uterine cancer	2.32e-05	0.000412	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRAS—uterine cancer	2.27e-05	0.000404	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ESR1—uterine cancer	2.21e-05	0.000393	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—uterine cancer	2.19e-05	0.000389	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1B—uterine cancer	2.15e-05	0.000381	CbGpPWpGaD
L-Arginine—NOS3—Disease—CTNNB1—uterine cancer	2.03e-05	0.00036	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTEN—uterine cancer	1.98e-05	0.000351	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—uterine cancer	1.96e-05	0.000347	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL2—uterine cancer	1.95e-05	0.000346	CbGpPWpGaD
L-Arginine—NOS3—Disease—EP300—uterine cancer	1.89e-05	0.000335	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CA—uterine cancer	1.8e-05	0.000319	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRAS—uterine cancer	1.76e-05	0.000313	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—uterine cancer	1.66e-05	0.000295	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTEN—uterine cancer	1.66e-05	0.000294	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB2—uterine cancer	1.62e-05	0.000288	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—EP300—uterine cancer	1.58e-05	0.000281	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL8—uterine cancer	1.54e-05	0.000274	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—uterine cancer	1.52e-05	0.00027	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1B—uterine cancer	1.5e-05	0.000267	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—uterine cancer	1.47e-05	0.000261	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CTNNB1—uterine cancer	1.42e-05	0.000252	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CA—uterine cancer	1.4e-05	0.000248	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTEN—uterine cancer	1.39e-05	0.000246	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EP300—uterine cancer	1.32e-05	0.000235	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—uterine cancer	1.29e-05	0.000229	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—uterine cancer	1.25e-05	0.000222	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRAS—uterine cancer	1.24e-05	0.000219	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CA—uterine cancer	1.17e-05	0.000208	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—uterine cancer	1.14e-05	0.000202	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—uterine cancer	1.06e-05	0.000189	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CA—uterine cancer	9.77e-06	0.000174	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—uterine cancer	9.55e-06	0.00017	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—uterine cancer	9.45e-06	0.000168	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—uterine cancer	9.04e-06	0.000161	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—uterine cancer	7.98e-06	0.000142	CbGpPWpGaD
